Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03217006 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03217006 · ClinicalTrials.gov record · last posted 2026-08-20

Randomization of Single vs Multiple Arterial Grafts

Study acronym: ROMA
StatusRecruiting
PhaseNot applicable
Started2018-01-07
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization. The secondary hypothesis is that in patients undergoing primary isolated non-emergent CABG, the use of two or more arterial grafts compared to a single arterial graft is associated with improved survival. Prospective event-driven unblinded randomized multicenter trial of at least 4,300 subjects enrolled in at least 25 international centers. Patients will be randomized to a single arterial graft (SAG) or multiple arterial grafts (MAG). Patients will be randomized in a 1:1 fashion between the two groups. Permuted block randomization with random blocks stratified by the center and the type of second arterial graft will be used to provide treatment distribution in equal proportion.

Protocol amendment history 2 changes detected by DataLookout

2026-08-21
critical
Primary completion pushed: 2027-06-30 → 2029-12-31
2026-08-21
minor
Completion pushed: 2030-01-01 → 2030-12-31
Trial Details
NCT Number NCT03217006
Lead Sponsor Weill Medical College of Cornell University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Canadian Institutes of Health Research (CIHR)
Conditions Coronary Artery Disease, Heart Diseases
Enrollment 4,300 participants
Start Date 2018-01-07
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-20